Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

balstilimab 2 zipalertinib 1 telisotuzumab vedotin 1 nirogacestat 1 mirdametinib 1 mifamurtide 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × zipalertinib × 30 days × Clear all

NCT07601399 2026-05-22

An EAP Treatment Protocol of Zipalertinib

Taiho Oncology, Inc.

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡